ns 1619 has been researched along with tadalafil in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angulo, J; Chen, M; Cuevas, P; Fernández, A; González-Corrochano, R; La Fuente, J; Sáenz de Tejada, I | 1 |
1 other study(ies) available for ns 1619 and tadalafil
Article | Year |
---|---|
Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
Topics: Adult; Aged; Animals; Benzimidazoles; Carbolines; Cyclic GMP; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation Therapy; Erectile Dysfunction; Humans; Male; Middle Aged; Nitric Oxide; Penis; Phosphodiesterase 5 Inhibitors; Piperazines; Potassium Channels, Calcium-Activated; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilation; Vasodilator Agents | 2013 |